京东方B2025年一季度报告(英文版)

FIRST QUARTERLY REPORT 2025 April 2025 BOE Technology Group Co., Ltd. First Quarterly Report 2025 2 Stock Code: 000725 Stock Name: BOE-A Announcement No. 2025-035 Stock Code: 200725 Stock Name: BOE-B Announcement No. 2025-035 BOE TECHNOLOGY GROUP CO., LTD. FIRST QUARTERLY REPORT 2025 BOE Technology Group Co., Ltd. (hereinafter referred to as the “Company”) and all the members of the Company’s Board of Directors hereby guarantee that the contents of this Report are true, accurate and complete and free of any misrepresentations, misleading statements or material omissions. Important Notes: The Board of Directors (or the “Board”), the Supervisory Committee as well as the directors, supervisors and senior management of BOE Technology Group Co., Ltd. (hereinafter referred to as the “Company”) hereby guarantee the factuality, accuracy and completeness of the contents of this Report and its summary, and shall be jointly and severally liable for any misrepresentations, misleading statements or material omissions therein. All the Company’s directors have attended the Board meeting for the review of this Report and its summary. Mr. Chen Yanshun, the Company’s legal representative, Mr. Feng Qiang, Chairman of the Executive Committee, Ms. Yang Xiaoping, Chief Financial Officer, and Ms. Xu Yaxiao, head of the financial department (equivalent to financial manager) hereby guarantee that the Financial Statements carried in this Report are factual, accurate and complete. This Report has been prepared in both Chinese and English. Should there be any discrepancies or misunderstandings between the two versions, the Chinese version shall prevail. The financial statements in this Report have not been audited by an independent auditor. BOE Technology Group Co., Ltd. First Quarterly Report 2025 3 I Key Financial Information (I) Key Accounting Data and Financial Indicators Indicate by tick mark whether there is any retrospectively restated datum in the table below. □Yes  No Item Q1 2025 Q1 2024 Change (%) Operating revenue (RMB) 50,598,933,939.00 45,887,570,444.00 10.27% Net profit attributable to the listed company’s shareholders (RMB) 1,613,999,380.00 983,812,692.00 64.06% Net profit attributable to the listed company’s shareholders before exceptional items (RMB) 1,351,864,713.00 596,689,345.00 126.56% Net cash generated from/used in operating activities (RMB) 13,743,795,736.00 16,230,705,070.00 -15.32% Basic earnings per share (RMB/share) 0.04 0.03 33.33% Diluted earnings per share (RMB/share) 0.04 0.03 33.33% Weighted average return on equity (%) 1.21% 0.76% 0.45% Item 31 March 2025 31 December 2024 Change (%) Total assets (RMB) 420,213,183,470.00 429,978,221,541.00 -2.27% Equity attributable to the listed c

立即下载
综合
2025-04-29
12页
0.75M
收藏
分享

京东方B2025年一季度报告(英文版),点击即可下载。报告格式为PDF,大小0.75M,页数12页,欢迎下载。

本报告共12页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
本报告共12页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
水滴研报所有报告均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
相关图表
表现出强大的发展韧性和活力,成为拉动经济增长的重要引擎。据中国汽车工业协会统计,2024
综合
2025-04-29
来源:上海永冠众诚新材料科技(集团)股份有限公司2024年年度报告摘要
查看原文
2018-2022 年中国医院精神科床位数(单位:万张)
综合
2025-04-29
来源:德展健康2024年年度报告
查看原文
全球多肽药物及 GLP1R 多肽药物市场规模及预测,以及全球多肽市场中国占比,2018-2030E
综合
2025-04-29
来源:德展健康2024年年度报告
查看原文
中国高胆固醇血症患者人数(2014 年至 2030 年(预测)),单位:百万人
综合
2025-04-29
来源:德展健康2024年年度报告
查看原文
中国慢病患病率,2008-2070E
综合
2025-04-29
来源:德展健康2024年年度报告
查看原文
2004-2018 年中国成人高血压知晓率、治疗率、控制率变化趋势
综合
2025-04-29
来源:德展健康2024年年度报告
查看原文
回顶部
报告群
公众号
小程序
在线客服
收起